Identification of shared pathogenetic mechanisms between endometriosis and RSA based on comprehensive bioinformatics analysis

article OA: closed CC0
AI-generated summary by claude@2026-06+body, 2026-06-12

This study identified FXYD1 as a shared hub gene between endometriosis and recurrent spontaneous abortion, finding it upregulated and potentially diagnostic, and correlated with immune cells, particularly NK cells.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-12 · read from full text

This bioinformatics study analyzed publicly available gene expression datasets for endometriosis (GSE7305) and recurrent spontaneous abortion (RSA; GSE165004), using differential expression analyses, functional enrichment, and weighted gene co-expression network analysis (WGCNA) to identify shared pathways and hub genes. The key finding was that FXYD1 was a shared upregulated hub gene across both conditions, with pathway enrichment related to abnormal proliferation, immune dysfunction, and developmental regulation; it showed diagnostic performance by ROC analysis and correlated with immune cell populations, especially natural killer (NK) cells. Single-cell RNA sequencing data further supported higher FXYD1 expression in stromal and decidual cells within RSA tissues, linking it to impaired decidualization. The paper does not explicitly state limitations in the provided excerpt, but it relies on re-analyses of existing transcriptomic datasets rather than new experimental perturbation. This paper is centrally about endometriosis—specifically identifying FXYD1 as a shared molecular hub mechanism between endometriosis and recurrent spontaneous abortion.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

PURPOSE: Endometriosis (EM) and recurrent spontaneous abortion (RSA) exhibit clinical associations, yet their shared molecular mechanisms remain unclear. This study aimed to identify shared molecular mechanisms and potential hub genes underlying EM and RSA. METHODS: Differentially expressed genes (DEGs) were identified from EM (GSE7305) and RSA (GSE165004) datasets. Functional enrichment and weighted gene co-expression network analysis (WGCNA) revealed shared pathways and key modules. Venny software was used to identify hub genes between DEGs and key module genes. The diagnostic value of FXYD1 was assessed via ROC analysis. Regulatory networks and immune cell infiltration were explored. Pan-cancer analysis was conducted to assess FXYD1's expression profile across tumor types. Single-cell RNA sequencing validated FXYD1 expression in EM tissues, maternal-fetal interface and RSA samples. RESULTS: DEGs in EM and RSA were enriched in pathways associated with abnormal proliferation, immune dysfunction, and developmental regulation. FXYD1 was identified as a shared hub gene, upregulated in both conditions, with potential diagnostic value. It was correlated with immune cell populations, particularly natural killer (NK) cells. Pan-cancer analysis revealed widespread FXYD1 downregulation across multiple cancer types. Single-cell RNA sequencing confirmed elevated FXYD1 expression in stromal and decidual cells of RSA tissues, implicating its role in impaired decidualization. CONCLUSIONS: FXYD1 emerges as a critical molecular link between EM and RSA, potentially contributing to decidualization dysfunction. Its dysregulation may underlie the shared pathophysiology of these conditions, offering new insights into their molecular mechanisms.
Full text 14,730 characters · extracted from oa-doi-fallback · 5 sections · click to expand

Abstract

Purpose Endometriosis (EM) and recurrent spontaneous abortion (RSA) exhibit clinical associations, yet their shared molecular mechanisms remain unclear. This study aimed to identify shared molecular mechanisms and potential hub genes underlying EM and RSA.

Methods

Differentially expressed genes (DEGs) were identified from EM (GSE7305) and RSA (GSE165004) datasets. Functional enrichment and weighted gene co-expression network analysis (WGCNA) revealed shared pathways and key modules. Venny software was used to identify hub genes between DEGs and key module genes. The diagnostic value of FXYD1 was assessed via ROC analysis. Regulatory networks and immune cell infiltration were explored. Pan-cancer analysis was conducted to assess FXYD1’s expression profile across tumor types. Single-cell RNA sequencing validated FXYD1 expression in EM tissues, maternal–fetal interface and RSA samples.

Results

DEGs in EM and RSA were enriched in pathways associated with abnormal proliferation, immune dysfunction, and developmental regulation. FXYD1 was identified as a shared hub gene, upregulated in both conditions, with potential diagnostic value. It was correlated with immune cell populations, particularly natural killer (NK) cells. Pan-cancer analysis revealed widespread FXYD1 downregulation across multiple cancer types. Single-cell RNA sequencing confirmed elevated FXYD1 expression in stromal and decidual cells of RSA tissues, implicating its role in impaired decidualization.

Conclusions

FXYD1 emerges as a critical molecular link between EM and RSA, potentially contributing to decidualization dysfunction. Its dysregulation may underlie the shared pathophysiology of these conditions, offering new insights into their molecular mechanisms. Access this article We’re sorry, something doesn't seem to be working properly. Please try refreshing the page. If that doesn't work, please contact support so we can address the problem. Similar content being viewed by others Data availability All transcriptome data were obtained from publicly available datasets from ArrayExpress (https://www.ebi.ac.uk/arrayexpress/) and the NCBI GEO database (https://www.ncbi.nlm.nih.gov/geo/), with detailed information provided in Supplementary Table S1.

References

Zondervan KT, Becker CM, Koga K, Missmer SA, Taylor RN, Viganò P. Endometriosis. Nat Rev Dis Primers. 2018;4:9. Kennedy S, Bergqvist A, Chapron C, D’Hooghe T, Dunselman G, Greb R, et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod. 2005;20:2698–704. Meuleman C, Vandenabeele B, Fieuws S, Spiessens C, Timmerman D, D’Hooghe T. High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertil Steril. 2009;92:68–74. Pellicer A, Oliveira N, Ruiz A, Remohí J, Simón C. Exploring the mechanism(s) of endometriosis-related infertility: an analysis of embryo development and implantation in assisted reproduction. Hum Reprod. 1995;10:91–7. Nyholt DR, Low SK, Anderson CA, Painter JN, Uno S, Morris AP, et al. Genome-wide association meta-analysis identifies new endometriosis risk loci. Nat Genet. 2012;44:1355–9. Sapkota Y, Steinthorsdottir V, Morris AP, Fassbender A, Rahmioglu N, De Vivo I, et al. Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism. Nat Commun. 2017;8: 15539. Zullo F, Spagnolo E, Saccone G, Acunzo M, Xodo S, Ceccaroni M, et al. Endometriosis and obstetrics complications: a systematic review and meta-analysis[J]. Fertil Steril. 2017;108:667-672.e665. Breintoft K, Pinnerup R, Henriksen TB, Rytter D, Uldbjerg N, Forman A, et al. Endometriosis and risk of adverse pregnancy outcome: a systematic review and meta-analysis. J Clin Med. 2021;10(4):667. Saraswat L, Ayansina DT, Cooper KG, Bhattacharya S, Miligkos D, Horne AW, et al. Pregnancy outcomes in women with endometriosis: a national record linkage study. BJOG. 2017;124:444–52. Boje AD, Egerup P, Westergaard D, Bertelsen MMF, Nyegaard M, Hartwell D, et al. Endometriosis is associated with pregnancy loss: a nationwide historical cohort study. Fertil Steril. 2023;119:826–35. Giuliani E, Parkin KL, Lessey BA, Young SL, Fazleabas AT. Characterization of uterine NK cells in women with infertility or recurrent pregnancy loss and associated endometriosis. Am J Reprod Immunol. 2014;72:262–9. Seshadri S, Sunkara SK. Natural killer cells in female infertility and recurrent miscarriage: a systematic review and meta-analysis. Hum Reprod Update. 2014;20:429–38. Yang S, Wang H, Li D, Li M. An estrogen-NK cells regulatory axis in endometriosis, related infertility, and miscarriage. Int J Mol Sci. 2024. https://doi.org/10.3390/ijms25063362. Abramiuk M, Grywalska E, Małkowska P, Sierawska O, Hrynkiewicz R, Niedźwiedzka-Rystwej P. The role of the immune system in the development of endometriosis. Cells. 2022. https://doi.org/10.3390/cells11132028. Vallvé-Juanico J, Houshdaran S, Giudice LC. The endometrial immune environment of women with endometriosis. Hum Reprod Update. 2019;25:564–91. Vidali A, Riccio LGC, Abrao MS. Endometriosis and recurrent pregnancy loss: two manifestations of the same underlying dysfunction? Fertil Steril. 2023;119:836–7. Phipson B, Lee S, Majewski IJ, Alexander WS, Smyth GK. Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression. Ann Appl Stat. 2016;10:946–63. Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation (Camb). 2021;2: 100141. Walter W, Sánchez-Cabo F, Ricote M. GOplot: an R package for visually combining expression data with functional analysis. Bioinformatics. 2015;31:2912–4. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9: 559. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. P roc: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12: 77. Sticht C, De La Torre C, Parveen A, Gretz N. MiRwalk: an online resource for prediction of microRNA binding sites. PLoS One. 2018;13:e0206239. Zhang Q, Liu W, Zhang HM, Xie GY, Miao YR, Xia M, et al. hTFtarget: a comprehensive database for regulations of human transcription factors and their targets. Genomics Proteomics Bioinformatics. 2020;18:120–8. Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90-97. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–504. Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453–7. Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77:e108–10. Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98-102. Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36:411–20. Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet. 2021;397:839–52. Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril. 2012;98:511–9. Pirtea P, Cicinelli E, De Nola R, de Ziegler D, Ayoubi JM. Endometrial causes of recurrent pregnancy losses: endometriosis, adenomyosis, and chronic endometritis. Fertil Steril. 2021;115:546–60. van Dijk EL, Auger H, Jaszczyszyn Y, Thermes C. Ten years of next-generation sequencing technology. Trends Genet. 2014;30:418–26. Fonseca MAS, Haro M, Wright KN, Lin X, Abbasi F, Sun J, et al. Single-cell transcriptomic analysis of endometriosis. Nat Genet. 2023;55:255–67. Shi S, Huang C, Tang X, Liu H, Feng W, Chen C. Identification and verification of diagnostic biomarkers for deep infiltrating endometriosis based on machine learning algorithms. J Biol Eng. 2024;18:70. Wei C, Wei Y, Cheng J, Tan X, Zhou Z, Lin S, et al. Identification and verification of diagnostic biomarkers in recurrent pregnancy loss via machine learning algorithm and WGCNA. Front Immunol. 2023;14: 1241816. Li Q, Shi J, Liu W. The role of Wnt/β-catenin-lin28a/let-7 axis in embryo implantation competency and epithelial-mesenchymal transition (EMT). Cell Commun Signal. 2020;18:108. Yu M, Qin K, Fan J, Zhao G, Zhao P, Zeng W, et al. The evolving roles of Wnt signaling in stem cell proliferation and differentiation, the development of human diseases, and therapeutic opportunities. Genes Dis. 2024;11: 101026. Franasiak JM, Holoch KJ, Yuan L, Schammel DP, Young SL, Lessey BA. Prospective assessment of midsecretory endometrial leukemia inhibitor factor expression versus ανβ3 testing in women with unexplained infertility. Fertil Steril. 2014;101:1724–31. Cuomo M, Florio E, Della Monica R, Costabile D, Buonaiuto M, Di Risi T, et al. Epigenetic remodelling of Fxyd1 promoters in developing heart and brain tissues. Sci Rep. 2022;12: 6471. Floyd RV, Wray S, Martín-Vasallo P, Mobasheri A. Differential cellular expression of FXYD1 (phospholemman) and FXYD2 (gamma subunit of Na, K-ATPase) in normal human tissues: a study using high density human tissue microarrays. Annals of Anatomy - Anatomischer Anzeiger. 2010;192:7–16. Rajasekaran SA, Huynh TP, Wolle DG, Espineda CE, Inge LJ, Skay A, et al. Na,K-ATPase subunits as markers for epithelial-mesenchymal transition in cancer and fibrosis. Mol Cancer Ther. 2010;9:1515–24. Hirakawa T, Goto M, Takahashi K, Iwasawa T, Fujishima A, Makino K, et al. Na+/K+ ATPase α1 and β3 subunits are localized to the basolateral membrane of trophectoderm cells in human blastocysts. Hum Reprod. 2022;37:1423–30. Madan P, Rose K, Watson AJ. Na/K-ATPase beta1 subunit expression is required for blastocyst formation and normal assembly of trophectoderm tight junction-associated proteins. J Biol Chem. 2007;282:12127–34. Vissers G, Giacomozzi M, Verdurmen W, Peek R, Nap A. The role of fibrosis in endometriosis: a systematic review. Hum Reprod Update. 2024;30:706–50. Chen M, Zhou Y, Xu H, Hill C, Ewing RM, He D, et al. Bioinformatic analysis reveals the importance of epithelial-mesenchymal transition in the development of endometriosis. Sci Rep. 2020;10:8442. Soni UK, Chadchan SB, Kumar V, Ubba V, Khan MTA, Vinod BSV, et al. A high level of TGF-B1 promotes endometriosis development via cell migration, adhesiveness, colonization, and invasiveness†. Biol Reprod. 2018;100:917–38. Wujak ŁA, Blume A, Baloğlu E, Wygrecka M, Wygowski J, Herold S, et al. FXYD1 negatively regulates Na+/K+-ATPase activity in lung alveolar epithelial cells. Respir Physiol Neurobiol. 2016;220:54–61. Somigliana E, Viganò P, Vignali M. Endometriosis and unexplained recurrent spontaneous abortion: pathological states resulting from aberrant modulation of natural killer cell function? Hum Reprod Update. 1999;5:40–51. Zhang X, Wei H. Role of decidual natural killer cells in human pregnancy and related pregnancy complications. Front Immunol. 2021;12: 728291. Wallace AE, Fraser R, Cartwright JE. Extravillous trophoblast and decidual natural killer cells: a remodelling partnership. Hum Reprod Update. 2012;18:458–71. Kidder GM. Trophectoderm development and function: the roles of Na+/K(+)-ATPase subunit isoforms. Can J Physiol Pharmacol. 2002;80:110–5. Pavlović D, Fuller W, Shattock MJ. The intracellular region of FXYD1 is sufficient to regulate cardiac Na/K ATPase. FASEB J. 2007;21:1539–46. Gan J, Yang L, Yang SH, Gu WW, Gu Y, Shi Y, et al. FXYD1 was identified as a hub gene in recurrent miscarriage and involved in decidualization via regulating Na/K-ATPase activity. J Assist Reprod Genet. 2024. https://doi.org/10.1007/s10815-024-03363-8. Floyd RV, Mobasheri A, Wray S. Gestation changes sodium pump isoform expression, leading to changes in ouabain sensitivity, contractility, and intracellular calcium in rat uterus. Physiol Rep. 2017;5:5. Zhao E, Gao K, Xiong J, Liu Z, Chen Y, Yi L. The roles of FXYD family members in ovarian cancer: an integrated analysis by mining TCGA and GEO databases and functional validations. J Cancer Res Clin Oncol. 2023;149:17269–84. Bubb KJ, Tang O, Gentile C, Moosavi SM, Hansen T, Liu CC, et al. FXYD1 is protective against vascular dysfunction. Hypertension. 2021;77:2104–16. Arystarkhova E, Bouley R, Liu YB, Sweadner KJ. Impaired AQP2 trafficking in Fxyd1 knockout mice: a role for FXYD1 in regulated vesicular transport. PLoS One. 2017;12: e0188006. Author information Authors and Affiliations Contributions JS, SYL, and YXW conceived and designed the research. JS performed the bioinformatics analysis and drafted the manuscript. YLD and YH collected clinical samples. YY conducted RT-qPCR analysis. YY, LZ, and ZPS reviewed the manuscript. All authors read and approved the final manuscript. Corresponding authors Ethics declarations Ethical approval The studies involving humans were approved by the Medical Ethics Committees of the Second Affiliated Hospital of Army Medical University (ID: 2024–311-02) and the First Affiliated Hospital of Chongqing Medical University (ID: 2023–075-02). The participants provided their written informed consent to participate in this study. Conflict of interest The authors declare no competing interests. Additional information Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Supplementary Information Below is the link to the electronic supplementary material. Rights and permissions Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. About this article Cite this article Sheng, J., Dong, Y., Yuan, Y. et al. Identification of shared pathogenetic mechanisms between endometriosis and RSA based on comprehensive bioinformatics analysis. J Assist Reprod Genet 42, 3047–3064 (2025). https://doi.org/10.1007/s10815-025-03596-1 Received: Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s10815-025-03596-1

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Abortion, Habitual Abortion, Habitual Abortion, Habitual Abortion, Habitual Abortion, Habitual Abortion, Habitual Abortion, Habitual Abortion, Habitual Abortion, Habitual Abortion, Habitual Abortion, Habitual Abortion, Habitual Abortion, Habitual Abortion, Habitual Abortion, Habitual Abortion, Habitual Abortion, Habitual Abortion, Habitual Abortion, Habitual Abortion, Habitual

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (65)

Source provenance

europepmc
last seen: 2026-07-26T06:08:39.051465+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pmc
last seen: 2026-05-17T02:30:03.883495+00:00
pubmed
last seen: 2026-07-26T06:04:40.205671+00:00
License: CC0 · commercial use OK